InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,543.22
(
1.61%
)
US TECH 100
19,002.00
(
2.66%
)
Dow Jones
40,563.06
(
1.39%
)
Brent Oil
80.37
(
-0.14%
)
Bitcoin
58,188.86
(
1.13%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

lax20m

Send PM Follow Ignore
Followers 16
Posts 2238
Boards Moderated 0
Alias Born 06/22/2010

lax20m

Re: NP1986 post# 12559

Thursday, 09/15/2011 12:36:23 PM

Thursday, September 15, 2011 12:36:23 PM

Post# of 80490
I think the opposite. I think that partnering Ponatanib in Europe would significantly decrease buy out speculation. Big Pharma is interested in acquiring the rights to the product globally, once they partner I think buy out chances decrease. And I don't see any company that plans on buying another company wasting their time trying to partner the drug that they will eventually own. Its not like these deals are done on the back of napkins at a coffee shop

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up